2012 annual financial data

Sarepta Therapeutics 2012 Financial results

Sarepta Therapeutics 2012 financial results with verified reported values.

Direct answer

Revenue was 37,329,000 USD.

Operating income was -29,703,000 USD and net income was -121,287,000 USD.
Operating cash flow was -29,694,000 USD.

Get free Sarepta Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
37,329,000 USD
Operating income
-29,703,000 USD
Net income
-121,287,000 USD
Operating cash flow
-29,694,000 USD